DCCCyB is an orally bioavailable, potent, and selective inhibitor of GlyT1 . DCCCyB demonstrates excellent in vivo occupancy of GlyT1 transporters in rhesus monkey.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GlyT
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.